| Oct 3 |
Valneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00 AM ET
|
| Sep 18 |
Valneva eyes teenage label for chikungunya vaccine in Europe and Canada
|
| Sep 18 |
Valneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ®, to EMA and Health Canada
|
| Sep 13 |
Valneva Announces the Success of its Private Placement Raising approximately €60 Million
|
| Sep 12 |
Valneva Announces the Launch of a Private Placement of Ordinary Shares for Approximately 60 Million Euros
|
| Sep 9 |
Esker And 2 Other High Growth Tech Stocks In France
|
| Sep 4 |
VALNEVA - Declaration of shares and voting rights: August 31, 2024
|
| Sep 3 |
Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study
|
| Sep 3 |
Favorable VLA15 Phase 2 Study Results Might Boost VALN Stock
|
| Sep 3 |
Valneva and Pfizer report positive data from trial of Lyme disease vaccine booster
|
